Briefing
Sequencing-based counting and size profiling of plasma Epstein-Barr virus DNA enhance population screening of nasopharyngeal carcinoma
Sequencing-based counting and fragment-size profiling of plasma EBV DNA improved the performance of population screening for nasopharyngeal carcinoma, building on the 2017 NEJM PCR screening study.
- Design: Evidence level 2
- Assay: Not named in the abstract
Proc Natl Acad Sci U S APubMed 29760067DOI 10.1073/pnas.1804184115